Physician profile
Peter B Morgan
NPI 1083853568
$1,333.14
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $52.79 · 2021: $58.64 · 2022: $196 · 2023: $313 · 2024: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $829.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $300.67 | 2019-2024 | Keytruda, Welireg, Lynparza |
| Myriad Genetic Laboratories, INC. | $189.70 | 2022-2024 | Myrisk |
| Tempus Ai, INC | $108.79 | 2024 | Xt Cdx |
| Astrazeneca Pharmaceuticals LP | $80.37 | 2024 | Imfinzi, Enhertu |
| E.R. Squibb & Sons, L.L.C. | $68.29 | 2019-2021 | |
| Davol INC. | $62.50 | 2023 | Arista Ah Flexitip |
| Ipsen Biopharmaceuticals, INC | $56.26 | 2019-2024 | Onivyde, Somatuline Depot |
| Lilly USA, LLC | $46.46 | 2019-2022 | |
| Conmed Corporation | $45.45 | 2023 | Airseal |
| Puma Biotechnology, INC. | $43.51 | 2022 | |
| Array Biopharma INC | $43.50 | 2023-2024 | Braftovi, Mektovi, Tukysa |
| Varian Medical Systems, INC. | $29.67 | 2019 | |
| Abbvie INC. | $29.14 | 2023 | |
| Celgene Corporation | $28.49 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $28.23 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $28.01 | 2023 | |
| Alexion Pharmaceuticals, INC. | $26.62 | 2024 | Ultomiris |
| Sobi, INC | $23.33 | 2024 | |
| Pharmaessentia USA Corporation | $22.35 | 2024 | Besremi |
| Mirati Therapeutics, INC. | $21.51 | 2024 | Krazati |
| Daiichi Sankyo INC. | $18.42 | 2019 | |
| Emd Serono, INC. | $17.68 | 2019 | |
| Janssen Biotech, INC. | $14.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.